FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082205511> ?p ?o ?g. }

• W3082205511 abstract "Abstract Background Pyroptosis is a type of proinflammatory regulated cell death (RCD) in which caspase-1 proteolytically cleaves gasdermin D (GSDMD) to yield a cytotoxic pore-forming protein. Recent studies have suggested that additional cell death pathways may interact with GSDMD under certain circumstances to execute pyroptosis. Microglia/macrophages in the central nervous system (CNS) undergo GSDMD-associated pyroptosis in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) but the contribution of other cell death pathways to this phenomenon is unknown. Herein, we tested the hypothesis that multiple RCD pathways underlie microglial pyroptosis in the context of neuroinflammation. Methods A siRNA screen of genes with known RCD functions was performed in primary human microglia to evaluate their role in nigericin-induced pyroptosis using supernatant lactate dehydrogenase activity as a read-out of cell lysis. Activation of apoptotic executioner proteins and their contribution to pyroptosis was assessed using semi-quantitative confocal microscopy, high-sensitivity ELISA, immunoblot, cell lysis assays, and activity-based fluorescent probes. Quantification of pyroptosis-related protein expression was performed in CNS lesions from patients with progressive MS and mice with MOG 35-55 -induced EAE, and in matched controls. Results Among progressive MS patients, activated caspase-3 was detected in GSDMD immunopositive pyroptotic microglia/macrophages within demyelinating lesions. In the siRNA screen, suppression of caspase-3/7, caspase-1, or GSDMD expression prevented plasma membrane rupture during pyroptosis. Upon exposure to pyroptotic stimuli (ATP or nigericin), human microglia displayed caspase-3/7 activation and cleavage of caspase-3/7-specific substrates (e.g., DFF45, ROCK1, and PARP), with accompanying features of pyroptosis including GSDMD immunopositive pyroptotic bodies, IL-1β release, and membrane rupture. Pyroptosis-associated nuclear condensation and pyroptotic body formation were suppressed by caspase-3/7 inhibition. Pharmacological and siRNA-mediated inhibition of caspase-1 diminished caspase-3/7 activation during pyroptosis. In mice with EAE-associated neurological deficits, activated caspase-3 colocalized with GSDMD immunopositivity in lesion-associated macrophages/microglia. Conclusions Activation of executioner caspases-3/7, widely considered key mediators of apoptosis, contributed to GSDMD-associated microglial pyroptosis under neuroinflammatory conditions. Collectively, these observations highlight the convergence of different cell death pathways during neuroinflammation and offer new therapeutic opportunities in neuroinflammatory disease." @default.
• W3082205511 created "2020-09-08" @default.
• W3082205511 creator A5036871246 @default.
• W3082205511 creator A5038583170 @default.
• W3082205511 creator A5049842711 @default.
• W3082205511 creator A5051557302 @default.
• W3082205511 creator A5077091632 @default.
• W3082205511 creator A5083635527 @default.
• W3082205511 date "2020-08-29" @default.
• W3082205511 modified "2023-10-17" @default.
• W3082205511 title "Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis" @default.
• W3082205511 cites W1742765381 @default.
• W3082205511 cites W1864325817 @default.
• W3082205511 cites W1882905539 @default.
• W3082205511 cites W1974885063 @default.
• W3082205511 cites W1980792888 @default.
• W3082205511 cites W1984304206 @default.
• W3082205511 cites W1985970823 @default.
• W3082205511 cites W2017922747 @default.
• W3082205511 cites W2024105041 @default.
• W3082205511 cites W2030586613 @default.
• W3082205511 cites W2043753343 @default.
• W3082205511 cites W2140637559 @default.
• W3082205511 cites W2142677020 @default.
• W3082205511 cites W2153180469 @default.
• W3082205511 cites W2316070165 @default.
• W3082205511 cites W2316285318 @default.
• W3082205511 cites W2461915818 @default.
• W3082205511 cites W2511127858 @default.
• W3082205511 cites W2517997111 @default.
• W3082205511 cites W2528029690 @default.
• W3082205511 cites W2531570683 @default.
• W3082205511 cites W2566478676 @default.
• W3082205511 cites W2605111984 @default.
• W3082205511 cites W2608687752 @default.
• W3082205511 cites W2735193465 @default.
• W3082205511 cites W2737470345 @default.
• W3082205511 cites W2766031263 @default.
• W3082205511 cites W2766062371 @default.
• W3082205511 cites W2766254014 @default.
• W3082205511 cites W2768333226 @default.
• W3082205511 cites W2770936091 @default.
• W3082205511 cites W2786796335 @default.
• W3082205511 cites W2788640168 @default.
• W3082205511 cites W2792448780 @default.
• W3082205511 cites W2801598991 @default.
• W3082205511 cites W2808342347 @default.
• W3082205511 cites W2888057265 @default.
• W3082205511 cites W2891569200 @default.
• W3082205511 cites W2895086405 @default.
• W3082205511 cites W2913221496 @default.
• W3082205511 cites W2918220183 @default.
• W3082205511 cites W2945002892 @default.
• W3082205511 cites W2947033822 @default.
• W3082205511 cites W2949199708 @default.
• W3082205511 cites W2970602413 @default.
• W3082205511 cites W2983652778 @default.
• W3082205511 cites W2995981280 @default.
• W3082205511 cites W3008585479 @default.
• W3082205511 doi "https://doi.org/10.1186/s12974-020-01902-5" @default.
• W3082205511 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7456507" @default.
• W3082205511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32861242" @default.
• W3082205511 hasPublicationYear "2020" @default.
• W3082205511 type Work @default.
• W3082205511 sameAs 3082205511 @default.
• W3082205511 citedByCount "36" @default.
• W3082205511 countsByYear W30822055112021 @default.
• W3082205511 countsByYear W30822055112022 @default.
• W3082205511 countsByYear W30822055112023 @default.
• W3082205511 crossrefType "journal-article" @default.
• W3082205511 hasAuthorship W3082205511A5036871246 @default.
• W3082205511 hasAuthorship W3082205511A5038583170 @default.
• W3082205511 hasAuthorship W3082205511A5049842711 @default.
• W3082205511 hasAuthorship W3082205511A5051557302 @default.
• W3082205511 hasAuthorship W3082205511A5077091632 @default.
• W3082205511 hasAuthorship W3082205511A5083635527 @default.
• W3082205511 hasBestOaLocation W30822055111 @default.
• W3082205511 hasConcept C139964883 @default.
• W3082205511 hasConcept C142724271 @default.
• W3082205511 hasConcept C151730666 @default.
• W3082205511 hasConcept C17172800 @default.
• W3082205511 hasConcept C185592680 @default.
• W3082205511 hasConcept C190283241 @default.
• W3082205511 hasConcept C203014093 @default.
• W3082205511 hasConcept C2776914184 @default.
• W3082205511 hasConcept C2776925932 @default.
• W3082205511 hasConcept C2777209026 @default.
• W3082205511 hasConcept C2777330628 @default.
• W3082205511 hasConcept C2779134260 @default.
• W3082205511 hasConcept C2779343474 @default.
• W3082205511 hasConcept C2779830541 @default.
• W3082205511 hasConcept C31573885 @default.
• W3082205511 hasConcept C41625074 @default.
• W3082205511 hasConcept C55493867 @default.
• W3082205511 hasConcept C71924100 @default.
• W3082205511 hasConcept C86803240 @default.
• W3082205511 hasConcept C87753298 @default.
• W3082205511 hasConcept C95444343 @default.
• W3082205511 hasConcept C98424977 @default.
• W3082205511 hasConceptScore W3082205511C139964883 @default.

• next